orantinib
(NHFDRBXTEDBWCZ-ZROIWOOFSA-N)
Structure
- SMILES
- OC(=O)CCc1c(C)[nH]c(c1C)/C=C/1\C(=O)Nc2c1cccc2
- Type(s)
- Investigational
- Molecular Formula:
- C18H18N2O3
- Molecular Weight:
- 310.347
- Log P:
- 3.2794
- Hydrogen Bond Acceptor:
- 4
- Hydrogen Bond Donor:
- 3
- TPSA:
- 82.19
- CAS Number(s):
- 210644-62-5; 252916-29-3; 1044712-39-1
Synonym(s)
1.
orantinib
2.
(Z)-3-(2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl)-propionic acid
3.
(Z)-3-(2,4-dimethyl-5-(2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-1H-pyrrol-3-yl)propionic acid
4.
SU 6668
5.
SU006668
6.
SU6668
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Brain Neoplasms | 15739567 | CTD | |
| 2 | Glioma | 15739567 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.